{"id":"W4304609073","doi":"10.1093/ofid/ofac535","title":"Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases","year":2022,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Shionogi; Sick Kids Foundation; Amplyx; Astellas Pharma; Ablynx; Karyopharm Therapeutics; Gilead Sciences; GlaxoSmithKline; Pfizer","keywords":"Medicine; Granulocyte macrophage colony-stimulating factor; Recombinant DNA; Adjuvant; Granulocyte colony-stimulating factor; Immunology; Colony-stimulating factor; Granulocyte; Internal medicine; Cytokine; Biology; Haematopoiesis; Chemotherapy; Stem cell; Cell biology; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004983667,0.0001465298,0.0003158471,0.0007201442,0.00005177219,0.0002190607,0.0001687454,0.0001693313,0.0005467925],"category_scores_gemma":[0.001040063,0.00004475118,0.000298086,0.00064344,0.0001368806,0.0001412735,0.0001001666,0.0001159074,0.0001394812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000177432,"about_ca_system_score_gemma":0.000399214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002019208,"about_ca_topic_score_gemma":0.0004009336,"domain_scores_codex":[0.9998148,0.00008092917,0.00004739982,0.00002069659,0.00002813804,0.000008004167],"domain_scores_gemma":[0.9993668,0.0003342695,0.0002136166,0.00002033433,0.00004261342,0.00002229083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002926464,0.000206987,0.05303997,0.02321206,0.0009757553,0.003764982,0.0001242561,0.0005839042,0.03440065,0.0004223645,0.003340954,0.8770016],"study_design_scores_gemma":[0.002422429,0.01514851,0.3691887,0.04646757,0.01127538,0.1038943,0.0008202358,0.003618111,0.1447552,0.001721601,0.3005873,0.0001005883],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1415736,0.8551623,0.0008387062,0.0003391498,0.000123064,0.00004048632,0.0001843734,0.00003086011,0.001707461],"genre_scores_gemma":[0.7032143,0.2928301,0.002767727,0.0003046052,0.000232777,0.00005032259,0.0002439247,0.000005920051,0.0003502413],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0007201442,"threshold_uncertainty_score":0.002635658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02595412161530459,"score_gpt":0.3355992346685612,"score_spread":0.3096451130532566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}